Form 4: Aspira Women's Health Director Exercises Restricted Stock Units
SEC Form 4
Director Ellen O'Connor Vos converted 5,313 restricted stock units into common stock of Aspira Women's Health Inc. on March 31, 2025.
Summary
- On March 31, 2025, Ellen O'Connor Vos, a director of Aspira Women's Health Inc., converted 5,313 restricted stock units (RSUs) into common stock.
- These RSUs were part of a grant of 21,250 RSUs awarded on August 22, 2024, with 5,313 vesting on March 31, 2025.
- Following the transaction, Vos directly owns 68,677 shares of Aspira Women's Health Inc. common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction filing related to stock options, and has a neutral sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Reporting person was granted 21,250 RSUs |
| 08/26/2024 | Previous Form 4 filing with the SEC regarding the RSU grant. |
| 03/31/2025 | 5,313 RSUs vested and were converted into common stock. |
| 04/02/2025 | Date of signature on the Form 4. |
Keywords
Aspira Women's Health Inc., Director, Ellen O'Connor Vos, Restricted Stock Units, RSUs, Common Stock, Beneficial Ownership, Form 4, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.